Liver Disease Clinical Trials

Showing 341-360 of 1,498 trials

Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care

NCT04178096

This Veteran Affairs (VA) Quality Improvement project aims to understand which data-driven implementation strategies promote evidence based practices that improve high-quality care for Veterans with cirrhosis.

Cirrhosis, Liver

VA Office of Research and Development12 participantsStarted Sep 2020

Pittsburgh, Pennsylvania, United States

RECRUITINGNA

Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients

NCT03506893

The hypothesis is that the Alfapump® strategy would be more effective in terms of QALYs generated , and that the cost of Alfapump® device and its implantation will be totally or partially offset by the reduction in the number of evacuating parentheses performed and the reduction in the number of complications in patients with refractory ascites awaiting liver transplantation or not. On the other hand, given the difference in the clinical profiles of these two populations (whether or not they are awaiting transplantation), these two populations will be study separately Evaluation of the medical-economic impact at 1 year of the two therapeutic strategies: implantation of Alfapump® versus repeated evacuating paracentesis in cirrhotic patients with refractory ascites without scheduled liver transplantation.

AscitesParacentesisCirrhosis

University Hospital, Grenoble90 participantsStarted Jul 2018

Amiens, France • Angers, France • Besançon, France +7 more locations

Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care

Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients

Related Searches

12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat

Nonalcoholic Steatohepatitis in Chinese Children

Longitudinal Observational Study Of Chinese With NAFLD/NASH

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.

Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological Characteristics

Risk of MASLD in Adults in Romania

Chronic Liver Disease and Radiation-induced Second Primary Liver Malignancy

Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status

Antidiabetic Drugs for Steatotic Liver Disease

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)

Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study

Observational Pharmaco-Epidemiology Research & Analysis

Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption

Replicor Compassionate Access Program

Influence of Sarcopenia on the Course of the Diseases